We found that levels of markers of inflammation (IL-6, Figure 8G; TNF-α, Figure 8H) and neurodegeneration (NfL, Figure 8I) were already elevated in ALS mice treated with vehicle by the first assessed time point of 2 months of age. Here, IL6 is linked to amyotrophic lateral sclerosis.